35090 spending records on file.
18 of 18 publications are not machine-readable
757 of 35090 lack meaningful descriptions
only 755 unique descriptions out of 35090 records
0 of 35090 missing supplier code
0 of 35090 missing supplier name
| Payment date* | Supplier | Description | Kind | Publication | Amount |
|---|---|---|---|---|---|
| 30 Mar 2026 | Alexion Pharma International O | Bespoke Funding Arrangements-Drugs | Purchase Order | Q1 2026 | €21,143.00 |
| 30 Mar 2026 | Alexion Pharma International O | Bespoke Funding Arrangements-Drugs | Purchase Order | Q1 2026 | €21,143.00 |
| 30 Mar 2026 | Alexion Pharma International O | Bespoke Funding Arrangements-Drugs | Purchase Order | Q1 2026 | €21,143.00 |
| 30 Mar 2026 | Alexion Pharma International O | Bespoke Funding Arrangements-Drugs | Purchase Order | Q1 2026 | €21,143.00 |
| 30 Mar 2026 | Alexion Pharma International O | Bespoke Funding Arrangements-Drugs | Purchase Order | Q1 2026 | €21,143.00 |
| 30 Mar 2026 | Alexion Pharma International O | Drugs & Medicines General | Purchase Order | Q1 2026 | €28,190.00 |
| 30 Mar 2026 | Alexion Pharma International O | Drugs & Medicines General | Purchase Order | Q1 2026 | €21,143.00 |
| 30 Mar 2026 | Alexion Pharma International O | Drugs & Medicines General | Purchase Order | Q1 2026 | €28,190.00 |
| 30 Mar 2026 | Alexion Pharma International O | Drugs & Medicines General | Purchase Order | Q1 2026 | €21,143.00 |
| 30 Mar 2026 | Alexion Pharma International O | Drugs & Medicines General | Purchase Order | Q1 2026 | €21,143.00 |
| 30 Mar 2026 | Alexion Pharma International O | Furnit H/ware & Crockery Offline Stock | Purchase Order | Q1 2026 | €28,190.00 |
| 30 Mar 2026 | Alexion Pharma International O | Bespoke Funding Arrangements-Drugs | Purchase Order | Q1 2026 | €28,190.00 |
| 30 Mar 2026 | Alexion Pharma International O | Bespoke Funding Arrangements-Drugs | Purchase Order | Q1 2026 | €28,190.00 |
| 30 Mar 2026 | Alexion Pharma International O | Bespoke Funding Arrangements-Drugs | Purchase Order | Q1 2026 | €28,190.00 |
| 30 Mar 2026 | Alexion Pharma International O | Bespoke Funding Arrangements-Drugs | Purchase Order | Q1 2026 | €28,190.00 |
| 30 Mar 2026 | Alexion Pharma International O | Drugs & Medicines General | Purchase Order | Q1 2026 | €21,143.00 |
| 30 Mar 2026 | Alexion Pharma International O | Furnit H/ware & Crockery Offline Stock | Purchase Order | Q1 2026 | €21,143.00 |
| 30 Mar 2026 | Alexion Pharma International O | Bespoke Funding Arrangements-Drugs | Purchase Order | Q1 2026 | €21,143.00 |
| 30 Mar 2026 | Alexion Pharma International O | Bespoke Funding Arrangements-Drugs | Purchase Order | Q1 2026 | €21,143.00 |
| 30 Mar 2026 | Alexion Pharma International O | Bespoke Funding Arrangements-Drugs | Purchase Order | Q1 2026 | €21,143.00 |
| 30 Mar 2026 | Alexion Pharma International O | Drugs & Medicines General | Purchase Order | Q1 2026 | €28,190.00 |
| 30 Mar 2026 | Alexion Pharma International O | Bespoke Funding Arrangements-Drugs | Purchase Order | Q1 2026 | €28,190.00 |
| 30 Mar 2026 | Alexion Pharma International O | Bespoke Funding Arrangements-Drugs | Purchase Order | Q1 2026 | €28,190.00 |
| 30 Mar 2026 | FANNIN LIMITED | Other Drugs & Medicines | Purchase Order | Q1 2026 | €69,188.00 |
| 30 Mar 2026 | FANNIN LIMITED | Med & Surgical Aids & Appliances Purch | Purchase Order | Q1 2026 | €39,939.00 |
| 30 Mar 2026 | FANNIN LIMITED | Med & Surgical Aids & Appliances Purch | Purchase Order | Q1 2026 | €46,521.00 |
| 30 Mar 2026 | FANNIN LIMITED | Aids & Appliances - Recycling & Repair | Purchase Order | Q1 2026 | €56,642.00 |
| 30 Mar 2026 | FANNIN LIMITED | Aids & Appliances - Recycling & Repair | Purchase Order | Q1 2026 | €94,543.00 |
| 30 Mar 2026 | FANNIN LIMITED | Aids & Appliances - Recycling & Repair | Purchase Order | Q1 2026 | €49,533.00 |
| 30 Mar 2026 | FANNIN LIMITED | Med & Surgical Aids & Appliances Purch | Purchase Order | Q1 2026 | €24,926.00 |
| 30 Mar 2026 | MLL MVZ GMBH | Laboratory External Services | Purchase Order | Q1 2026 | €30,395.00 |
| 30 Mar 2026 | MLL MVZ GMBH | Laboratory External Services | Purchase Order | Q1 2026 | €29,215.00 |
| 30 Mar 2026 | BAYER LTD IRELAND | Other Drugs & Medicines | Purchase Order | Q1 2026 | €93,972.00 |
| 30 Mar 2026 | LINKEDIN IRELAND UNLIMITED COM | S/ware chgs inc Maint/Sup/A'ual Lice Chg | Purchase Order | Q1 2026 | €38,315.00 |
| 30 Mar 2026 | DIRECT MEDICAL LTD | Rent/Lease of Medical Equipment | Purchase Order | Q1 2026 | €94,920.00 |
| 30 Mar 2026 | DIRECT MEDICAL LTD | Rent/Lease of Medical Equipment | Purchase Order | Q1 2026 | €23,426.00 |
| 30 Mar 2026 | ABBOTT LABORATORIES IRL LTD | Laboratory/Pathology Supplies | Purchase Order | Q1 2026 | €35,507.00 |
| 30 Mar 2026 | ENERGIA | Electricity | Purchase Order | Q1 2026 | €21,513.00 |
| 30 Mar 2026 | ENERGIA | Electricity | Purchase Order | Q1 2026 | €263,106.00 |
| 30 Mar 2026 | EHF29 LTD | Other Professional Fees Clinical | Purchase Order | Q1 2026 | €20,398.00 |
| 30 Mar 2026 | AIR LIQUIDE HEALTHCARE IRELAND | Med & Surgical Aids & Appliances Purch | Purchase Order | Q1 2026 | €97,426.00 |
| 30 Mar 2026 | AFFIDEA DIAGNOSTICS IRELAND LT | Medical Hospital Treatments Private | Purchase Order | Q1 2026 | €116,800.00 |
| 30 Mar 2026 | ROCHE DIAGNOSTICS | Laboratory External Services | Purchase Order | Q1 2026 | €420,888.00 |
| 30 Mar 2026 | IRISH WATER Srv | Water Rates/Charges - Business Water | Purchase Order | Q1 2026 | €228,440.00 |
| 30 Mar 2026 | BORD GAIS EIREANN | Gas | Purchase Order | Q1 2026 | €32,276.00 |
| 30 Mar 2026 | SAMSUNG BIOEPIS NL BV | Other Drugs & Medicines | Purchase Order | Q1 2026 | €20,053.00 |
| 30 Mar 2026 | SAMSUNG BIOEPIS NL BV | Bespoke Funding Arrangements-Drugs | Purchase Order | Q1 2026 | €20,053.00 |
| 30 Mar 2026 | ESSITY IRELAND LTD | Goods Received Note pending invoice | Purchase Order | Q1 2026 | €55,324.00 |
| 30 Mar 2026 | UNITED DRUG BALLINA 2 | Other Drugs & Medicines | Purchase Order | Q1 2026 | €38,639.00 |
| 30 Mar 2026 | UNIJOBS LTD | Mgt/Admin Agency Staff | Purchase Order | Q1 2026 | €52,152.00 |
* Payment date may be the end of the reporting quarter when the entity does not publish an exact date.